Poland· PL-100473988
Deporium
A tranexamic acid product containing acidum tranexamicum, registered in Poland by Adamed Pharma S.A.. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Tranexamic acid is registered in 15 of 19 countries.
Countries holding a registration under ATC B02AA02 (tranexamic acid), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Tranexamic acid · ATC B02AA02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tranexamic acid costs, country by country.
Normalised to the WHO defined daily dose (2 g), the median price runs from $1.69 in Italy to $34.44 in Switzerland — a ×20 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tranexamic acid · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$34.44
- IT Italy$1.69
The record
At a glance
URPL (Poland)- Active substance
- Acidum tranexamicum
- Manufacturer
- Adamed Pharma S.A.
- Country
- Poland (PL)
- ATC code
- B02AA02
- ATC class
- Tranexamic acid
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 8
- gtin05900411013697
- gtin05900411013734
- gtin05900411013765
- gtin05900411013727
- gtin05900411013710
- gtin05900411013741
- gtin05900411013703
- gtin05900411013758
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
45 interactions on record for tranexamic acid.
Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tranexamic acid · interactions on record
45 records
- 36 severe
- 8 moderate
- 1 minor
Most severe, free to view
- Faktor VIII-Inhibitor Bypass Aktivität - FEIBAB02BD03severe
- EstradiolD11AX34severe
- IUP aus Plastik mit GestagenG02BA03severe
- Levonorgestrel and ethinylestradiolG03AA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tranexamic acid in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCyklo-f Heavy Period Relief 500mg tabletsThe Boots Company Plc
- United StatesCyklokapronPfizer Laboratories Div Pfizer Inc
- CzechiaEXACYLCHEPLAPHARM Arzneimittel GmbH, Greifswald
- SwedenCyklo-f 500 mg Filmdragerad tablettViatris AB
- SwitzerlandCyklokapron
- BelgiumCyklokapron 100 mg/mlPfizer
- FinlandCaprilonEvolan Pharma AB
- CanadaCYKLOKAPRON 100 MG/MLPFIZER CANADA ULC
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Cyklokapron, Tranexamsäure Baxter
- Belgium · Acide Tranexamique Kabi, Cyklokapron
- Bulgaria · Медокапрон, Т-Капрон
- Cyprus · Azeptil, Medsamic
- Czechia · Exacyl, Tranexamic Acid Accord
- Germany · Cyklokapron, Cyklokapron-Injektionslösung
- Denmark · Cyklokapron, Cyklonova
- Estonia · Cyklokapron, Medsamic
- Spain · Ácido Tranexámico Baxter, Ácido Tranexámico Viatris
- Finland · Caprilon, Cyklokapron
- France · Acide Tranexamique Accord, Acide Tranexamique Aguettant
- United Kingdom (Northern Ireland) · Cyklo-F, Cyklokapron
- Greece · Tranexamic Acid /Kabi, Tranexamic Acid Baxter
- Croatia · Medsamic, Trenolk
- Hungary · Exacyl, Nimra
- Ireland · Cyklokapron, Tranexamic Acid Accord Healthcare Ireland
- Iceland · Cyklokapron, Tranexamsyre Pfizer
- Italy · Acido Tranexamico Adamed, Acido Tranexamico Aurobindo
- Lithuania · Haixa, Tranexamic Acid Baxter
- Luxembourg · Exacyl, Tranexamsäure Dr. Eberth
- Latvia · Cyklokapron, Haixa
- Malta · Azeptil, Medsamic
- Netherlands · Cyklokapron, Nexag
- Norway · Cyklokapron, Pilexam
- Portugal · Ácido Tranexâmico A.Forall, Ácido Tranexâmico Accord
- Romania · Acid Tranexamic Kabi, Medsamic
- Sweden · Cyklo-F, Cyklokapron
- Slovenia · Medsamic, Trenolk
- Slovakia · Medsamic, Tranexamic Acid Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9497a3ef-2da1-4ace-bd48-b8130cf4d045 GET /v1/drugs/9497a3ef-2da1-4ace-bd48-b8130cf4d045?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "1000 mg",
"packaging": "05900411013697 ¦ Rp ¦ 160315\n15 tabl.\n05900411013734 ¦ Rp ¦ 160316\n60 tabl.\n05900411013765 ¦ Rp ¦ 160317\n100 tabl.\n05900411013727 ¦ Rp ¦ 160318\n45 tabl.\n05900411013710 ¦ Rp ¦ 160319\n30 tabl.\n05900411013741 ¦ Rp ¦ 160320\n75 tabl.\n05900411013703 ¦ Rp ¦ 160321\n20 tabl.\n05900411013758 ¦ Rp ¦ 160322\n90 tabl.",
"substance": "Acidum tranexamicum 1000 mg",
"common_name": "Acidum tranexamicum",
"pl_product_id": "100473988",
"pozwolenie_nr": "28749",
"auth_procedure": "NAR",
"authorisation_validity": "2030-03-14"
}See everything about tranexamic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.